Dulaglutide
Weekly GLP-1 Receptor Agonists in Obese Individuals Without Diabetes
Company n/r · Phase 3 · Completed · Enrollment 150
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Dulaglutide Group | Obesity or overweight | n/r | 24 | n/r | n/r |
| Semaglutide Group | Obesity or overweight | n/r | 24 | n/r | n/r |
| Tirzepatide Group | Obesity or overweight | n/r | 24 | n/r | n/r |